The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors
Open accessAbstract
A subset of gastrointestinal stromal tumors (GISTs) lack gain-of-function mutations in c- KIT and PDGFR α. These so-called wild-type (WT) GISTs tend to be less responsive to imatinib-based therapies and have a poor prognosis. We identified amplification of IGF1R in a SNP analysis of GIST and thus studied its potential as a therapeutic target in WT and mutant GIST. Expression of IGF1R and downstream effectors in clinical GIST samples was examined by using immunoblots and immunohistochemistry. The roles of IGF1R signaling in GIST and viability were analyzed by using NVP-AEW541, an inhibitor of IGF1R, alone and in combination with imatinib, or via siRNA silencing of IGF1R. IGF1R was strongly overexpressed, and IGF1R amplification was detected at a significantly higher frequency in WT GISTs, including a pediatric WT GIST, compared with mutant GISTs ( P = 0.0173 and P = 0.0163, respectively). Inhibition of IGF1R activity in vitro with NVP-AEW541 or down-regulation of expression with siIGF1R led to cytotoxicity and induced apoptosis in GIST cell lines via AKT and MAPK signaling. Combination of NVP-AEW541 and imatinib in GIST cell lines induced a strong cytotoxicity response. Our results reveal that IGF1R is amplified and the protein is overexpressed in WT and pediatric GISTs. We also demonstrate that the aberrant expression of IGF1R may be associated with oncogenesis in WT GISTs and suggest an alternative and/or complementary therapeutic regimen in the clinical management of all GISTs, especially in a subset of tumors that respond less favorably to imatinib-based therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
Demetri, G. D., von Mehren, M., Blanke, C. D., Van den Abbeele, A. D., Eisenberg, B., Roberts, P. J., Heinrich, M. C., Tuveson, D. A., Singer, S., Janicek, M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020461 · Cited by 4,389
Self-citationmTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
O'Reilly, K. E., Rojo, F., She, Q.-B., Solit, D., Mills, G. B., Smith, D., Lane, H., Hofmann, F., Hicklin, D. J., Ludwig, D. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2925 · Cited by 2,561
Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
Heinrich, M. C., Corless, C. L., Demetri, G. D., Blanke, C. D., von Mehren, M., Joensuu, H., McGreevey, L. S., Chen, C.-J., Van den Abbeele, A. D., Druker, B. J., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.190 · Cited by 2,299
Self-citationVerweij, J., Casali, P. G., Zalcberg, J., LeCesne, A., Reichardt, P., Blay, J.-Y., Issels, R., van Oosterom, A., Hogendoorn, P. C., Van Glabbeke, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17098-0 · Cited by 1,665
Buchdunger, E., Cioffi, C. L., Law, N., Stover, D., Ohno-Jones, S., Druker, B. J., & Lydon, N. B. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38879-2 · Cited by 1,274
Faivre, S., Delbaldo, C., Vera, K., Robert, C., Lozahic, S., Lassau, N., Bello, C., Deprimo, S., Brega, N., Massimini, G., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.2194 · Cited by 1,164
The insulin-like growth factor system and cancer
LeRoith, D., & Roberts, C. T. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00159-9 · Cited by 1,124
Heinrich, M. C., Griffith, D. J., Druker, B. J., Wait, C. L., Ott, K. A., & Zigler, A. J. (2000) · Blood · doi:10.1182/blood.v96.3.925 · Cited by 1,071
Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies
Stommel, J. M., Kimmelman, A. C., Ying, H., Nabioullin, R., Ponugoti, A. H., Wiedemeyer, R., Stegh, A. H., Bradner, J. E., Ligon, K. L., Brennan, C., et al. (2007) · Science · doi:10.1126/science.1142946 · Cited by 938
Garcı́a-Echeverrı́a, C., Pearson, M. A., Marti, A., Meyer, T., Mestan, J., Zimmermann, J., Gao, J., Brueggen, J., Capraro, H.-G., Cozens, R., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00051-0 · Cited by 542
Debiec-Rychter, M., Dumez, H., Judson, I., Wasag, B., Verweij, J., Brown, M., Dimitrijevic, S., Sciot, R., Stul, M., Vranck, H., et al. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.11.025 · Cited by 444
Morabito, A., De Maio, E., Di Maio, M., Normanno, N., & Perrone, F. (2006) · The Oncologist · doi:10.1634/theoncologist.11-7-753 · Cited by 274
Prakash, S., Sarran, L., Socci, N., DeMatteo, R. P., Eisenstat, J., Greco, A. M., Maki, R. G., Wexler, L. H., LaQuaglia, M. P., Besmer, P., et al. (2005) · Journal of Pediatric Hematology/Oncology · doi:10.1097/01.mph.0000157790.81329.47 · Cited by 271
El-Rifai, W. M., Sarlomo‐Rikala, M., Andersson, L. C., Knuutila, S., & Miettinen, M. (2000) · PubMed · Cited by 224
Interaction of IGF signaling and the androgen receptor in prostate cancer progression.
Wu, J. D., Haugk, K., Woodke, L., Nelson, P., Coleman, I., & Plymate, S. R. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20929 · Cited by 188
Warshamana-Greene, G. S., Litz, J., Buchdunger, E., García-Echeverría, C., Hofmann, F., & Krystal, G. W. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1544 · Cited by 184
Janeway, K. A., Liegl, B., Harlow, A., Le, C., Perez-Atayde, A., Kozakewich, H., Corless, C. L., Heinrich, M. C., & Fletcher, J. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1938 · Cited by 173
Subramanian, S., West, R. B., Corless, C. L., Ou, W., Rubin, B. P., Chu, K., Leung, S. Y., Yuen, S. T., Zhu, S., Hernandez‐Boussard, T., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1208056 · Cited by 149
Gastric GI stromal tumors (GISTs): The role of surgery in the era of targeted therapy
Heinrich, M. C., & Corless, C. L. (2005) · Journal of Surgical Oncology · doi:10.1002/jso.20230 · Cited by 129
Tarn, C., Merkel, E., Canutescu, A. A., Shen, W., Skorobogatko, Y. V., Heslin, M. J., Eisenberg, B. L., Birbe, R., Patchefsky, A. S., Dunbrack, R. L., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2515 · Cited by 120
Self-citationSachdev, D., Singh, R., Fujita‐Yamaguchi, Y., & Yee, D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3126 · Cited by 119
Bench to Bedside and Back Again: Personalizing Treatment for Patients with GIST
Godwin, A. K. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0709 · Cited by 109
Self-citationRoith, D. L. (1999) · Hormone and Metabolic Research · doi:10.1055/s-2007-978696 · Cited by 108
Type I Insulin-like Growth Factor Receptor as a Therapeutic Target in Cancer
Miller, B. S., & Yee, D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2752 · Cited by 107
Höpfner, M., Huether, A., Sutter, A. P., Baradari, V., Schuppan, D., & Scherübl, H. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.02.006 · Cited by 106
Meza‐Zepeda, L. A., Kresse, S. H., Barragan-Polania, A. H., Bjerkehagen, B., Ohnstad, H. O., Namløs, H. M., Wang, J., Kristiansen, B., & Myklebost, O. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1972 · Cited by 103
Hailey, J., Maxwell, E., Koukouras, K., Bishop, W. R., Pachter, J. A., & Wang, Y. (2002) · PubMed · Cited by 92
Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients
Braconi, C., Bracci, R., Bearzi, I., Bianchi, F., Sabato, S., Mandolesi, A., Belvederesi, L., Cascinu, S., Valeri, N., & Cellerino, R. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn040 · Cited by 86
Tarn, C., Skorobogatko, Y. V., Taguchi, T., Eisenberg, B. L., von Mehren, M., & Godwin, A. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3906 · Cited by 78
Self-citationHöpfner, M., Baradari, V., Huether, A., Schöfl, C., & Scherübl, H. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01090 · Cited by 71
Clinical and molecular characteristics of pediatric gastrointestinal stromal tumors (GISTs)
Price, V. E., Zieleńska, M., Chilton‐MacNeill, S., Smith, C. S., & Pappo, A. S. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20377 · Cited by 70
Yanochko, G. M., & Eckhart, W. (2006) · Breast Cancer Research · doi:10.1186/bcr1392 · Cited by 66
Transcriptional regulation of the insulin-like growth factor-I receptor gene in breast cancer
Sarfstein, R., Maor, S., Reizner, N., Abramovitch, S., & Werner, H. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.03.018 · Cited by 64
Armengol, G., Knuutila, S., Lluı́s, F., Capellá, G., Miró, R., & Caballín, M. R. (2000) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(99)00118-1 · Cited by 58
The insulin‐like growth factor I receptor gene is the target for the 15q26 amplicon in breast cancer
Almeida, A., Muleris, M., Dutrillaux, B., & Malfoy, B. (1994) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870110110 · Cited by 56
Cited by
NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors
Demetri, G. D., von Mehren, M., Antonescu, C. R., DeMatteo, R. P., Ganjoo, K. N., Maki, R. G., Pisters, P. W. T., Raut, C. P., Riedel, R. F., Schuetze, S., et al. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0116 · Cited by 1,219
Self-citationGastrointestinal stromal tumours: origin and molecular oncology
Corless, C. L., Barnett, C. M., & Heinrich, M. C. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3143 · Cited by 891
He, M., Crow, J., Roth, M., Zeng, Y., & Godwin, A. K. (2014) · Lab on a Chip · doi:10.1039/c4lc00662c · Cited by 499
Self-citationGastrointestinal stromal tumours
Blay, J.-Y., Kang, Y.-K., Nishida, T., & von Mehren, M. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00254-5 · Cited by 460
Self-citationGastrointestinal stromal tumors
Liegl-Atzwanger, B., Fletcher, J. A., & Fletcher, C. D. M. (2010) · Virchows Archiv · doi:10.1007/s00428-010-0891-y · Cited by 397
Metadata
- Authors
- Tarn, C., Rink, L., Merkel, E., Flieder, D., Pathak, H., Koumbi, D., Testa, J. R., Eisenberg, B., von Mehren, M., & Godwin, A. K.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2008-06-17
- Volume
- 105
- Issue
- 24
- Pages
- 8387-8392
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1971736092
- Cited by
- 252
- References
- 35
- FWCI
- 25.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.